trending Market Intelligence /marketintelligence/en/news-insights/trending/47tzdqwzsd9l7he4wqjcsg2 content esgSubNav
In This List

Johnson & Johnson's laser eye surgery system bags US FDA approval

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Johnson & Johnson's laser eye surgery system bags US FDA approval

Johnson & Johnson said the U.S. Food and Drug Administration approved its iDESIGN refractive studio system used in laser eye surgery for treating certain vision conditions.

The New Brunswick, N.J.-based company's unit Johnson & Johnson Vision Care, Inc. said the system is used to treat myopia, hyperopia and mixed astigmatism — a condition causing blurred vision.

Johnson & Johnson said the system will allow doctors to take a precise measurement of the eye inside and out to deliver a LASIK procedure that is personalized for each patient.

In addition, the company said the iDESIGN system is the only available LASIK platform used for monovision in presbyopic myopic patients.

Monovision is a procedure for patients over 40 years of age who experience blurry near vision due to the aging of their eyes.